Short TB prevention for household contacts
Treatments studied
Part of Infections clinical trials.
This trial tests two shorter treatments (1HP or 3HR) to prevent TB infection from becoming active disease. It is for adults who live with someone who has drug-sensitive TB and have a positive test for TB infection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have lived with someone who has drug-sensitive TB and is being treated
- You have a positive TB infection test (blood or skin test)
- You are at least 18 years old
- You can stay in touch with the study team and have no plans to move away
- You are not pregnant or planning pregnancy in the next 4 months, and have no serious liver problems
- You weigh at least 30 kg (66 lbs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a short course of medication can prevent tuberculosis (TB) in children and teenagers who have been in close contact with someone who has active TB. The goal is to see if this approach can stop them from developing the disease.
This trial tests a very short (one-month) medicine course to prevent tuberculosis (TB) in students and school staff who have been exposed to someone with active TB. If you have latent TB infection (the germs are in your body but you're not sick), this treatment aims to stop it from turning into active TB disease.
This study aims to help find and start TB prevention medicine for people who have been in close contact with someone sick with TB. The goal is to protect more people, especially children, from getting sick.
This trial tests a shorter, safer treatment for people with latent TB infection (TB germs in your body but not making you sick). The goal is to prevent you from getting sick with active TB later.
This trial tests if a shorter treatment course works as well as the standard one for people whose chest X-rays suggest TB but whose sputum tests are negative. It aims to make treatment easier for patients.
This trial studies whether a rifapentine-based TB regimen can work just as well while shortening treatment time. It’s for people with rifampicin-sensitive, smear-positive lung tuberculosis.
Hear when a new Tuberculosis Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.